English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 857787      Online Users : 816
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/1157


    Title: Biosynthesis of human-type N-glycans in heterollogous systems
    Authors: Betenbaugh, MJ;Tomiya, N;Narang, S;Hsu, JTA;Lee, YC
    Contributors: Division of Biotechnology and Pharmaceutical Research
    Abstract: Insects, yeasts and plants generate widely different N-glycans, the structures of which differ significantly from those produced by mammals. The processing of the initial GlC(2)Man(9)GlcNAc(2) oligosaccharide to Man(8)GlcNAc(2) in the endoplasmic reticulum shows significant similarities among these species and with mammals, whereas very different processing events occur in the Golgi compartments. For example, yeasts can add 50 or even more Man residues to Man(8-9)GlcNAc(2), whereas insect cells typically remove most or all Man residues to generate paucimannosidic Man(3-1)GIcNAc(2) N-glycans. Plant cells also remove Man residues to yield Man(4-5)GlcNAc(2), with occasional complex GlcNAc or Gal modifications, but often add potentially allergenic beta(1,2)-linked Xyl and, together with insect cells, core alpha(1,3)-linked Fuc residues. However, genomic efforts, such as expression of exogenous glycosyltransferases, have revealed more complex processing capabilities in these hosts that are not usually observed in native cell lines. In addition, metabolic engineering efforts undertaken to modify insect, yeast and plant N-glycan processing pathways have yielded sialylated complex-type N-glycans in insect cells, and galactosylated N-glycans in yeasts and plants, indicating that cell lines can be engineered to produce mammalian-like glycoproteins of potential therapeutic value.
    Keywords: Biochemistry & Molecular Biology;Cell Biology
    Date: 2004-10
    Relation: Current Opinion in Structural Biology. 2004 Oct;14(5):601-606.
    Link to: http://dx.doi.org/10.1016/j.sbi.2004.09.001
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0959-440X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000224718800013
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=4744363988
    Appears in Collections:[徐祖安] 期刊論文

    Files in This Item:

    File Description SizeFormat
    000224718800013.pdf144KbAdobe PDF597View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback